Thrombotic thrombocytopenic purpura in a patient with lenalidomide-responsive multiple myeloma

Ann Hematol. 2015 Sep;94(9):1605-7. doi: 10.1007/s00277-015-2421-0. Epub 2015 Jun 5.

Authors

Chan Yoon Cheah¹, Robert Z Orlowski, Elisabet E Manasanch, Thein H Oo

Affiliation

¹ Department of Lymphoma/Myeloma, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA, ccheah@iinet.net.au.

PMID: 26044891
DOI: 10.1007/s00277-015-2421-0

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged, 80 and over
Angiogenesis Inhibitors / administration & dosage
Angiogenesis Inhibitors / adverse effects*
Female
Humans
Lenalidomide
Multiple Myeloma* / blood
Multiple Myeloma* / pathology
Multiple Myeloma* / therapy
Purpura, Thrombotic Thrombocytopenic* / blood
Purpura, Thrombotic Thrombocytopenic* / chemically induced
Purpura, Thrombotic Thrombocytopenic* / drug therapy
Purpura, Thrombotic Thrombocytopenic* / pathology
Thalidomide / administration & dosage
Thalidomide / adverse effects
Thalidomide / analogs & derivatives*

Substances

Angiogenesis Inhibitors
Thalidomide
Lenalidomide